Company: MYSEW
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004290
Chunk: 589

Company: Myseum, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 3
Chunk 589
---
 directors since December 2022. Mr. Shelus has
over 10 years of ephemeral messaging and mobile video development experience. Mr. Shelus has been at the forefront of the secure messaging
industry, having served as a lead engineer for one of the first ephemeral messaging platforms, “BigString,” where he helped
develop the patented technology that became a cornerstone of self-destructing messaging. Mr. Shelus holds Bachelor of Science degree
in computer science from Rutgers University. We believe that Mr. Shelus is qualified to serve as a member of our board of directors because
of his experience in the secure messaging industry and background in technology engineering and development.

Brett Blumberg – Chief Financial
Officer

Brett Blumberg has served as our Chief Financial
Officer since February 2022. Mr. Blumberg has extensive experience in finance and accounting. He is a certified public accountant and
has been a partner of the public accounting firm Jubran, Shorr & Company since 2015. Mr. Blumberg was a senior accountant at
CohnReznick, LLP from 2013 to 2014. Prior to obtaining his CPA license Mr. Blumberg was a private banker at Wells Fargo and owned and
operated a Mortgage Brokerage/Banking Company, Canyon Financial Group, LLC from 2006 to 2012. He previously worked in recruitment and
talent acquisition for accounting and finance firms from 2000 to 2006. Mr. Blumberg holds a Bachelor of Art degree in economics and psychology
from SUNY Binghamton University.

Wayne D. Linsley – Director

Wayne D. Linsley has served as a member of the
board of directors since August 2021. Mr. Linsley has over 40 years of experience in business management. Since April 2020, Mr. Linsley
has served as a member of the board of directors of Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company
and since January 2020, he has served as a member of the board of directors of Silo Pharma, Inc. (NASDAQ: SILO) a biopharmaceutical company
focused on merging traditional therapeutics with psychedelic research. From 2014 to September 2021, Mr. Linsley served as the Vice President
of Operations at CFO Oncall, Inc., a company that provides financial reporting